CCRN - Cross Country Healthcare Q2 Non-GAAP EPS revenue beats Q3 guidance provided
- Cross Country Healthcare press release ( NASDAQ: CCRN ): Q2 Non-GAAP EPS of $1.40 (vs. $0.47 Y/Y) beats by $0.05 .
- Revenue of $753.6M (+127.1% Y/Y) beats by $12.66M .
- Q3 Revenue to be in the range of $605M to $615M (vs. consensus of $587.1M), EPS to be in the range of $0.85 to $0.95 (vs. consensus of $0.91)
- Shares -6.16% .
For further details see:
Cross Country Healthcare Q2 Non-GAAP EPS, revenue beats, Q3 guidance provided